Barchart.com
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)
31.00 x 1 33.00 x 1
Post-market by (Cboe BZX)
31.65 +0.09 (+0.29%) 03/27/25 [NASDAQ]
31.00 x 1 33.00 x 1
Post-market 31.65 unch (unch) 16:34 ET
News & Headlines for Thu, Mar 27th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Royalty Pharma Announces Upcoming Investor Day GlobeNewswire - Thu Mar 27, 7:15AM CDT

RPRX : 31.65 (+0.29%)
RPRX
3 Reasons to Sell RPRX and 1 Stock to Buy Instead StockStory - Wed Mar 26, 10:43AM CDT

3 Reasons to Sell RPRX and 1 Stock to Buy Instead

META : 602.58 (-1.37%)
RPRX : 31.65 (+0.29%)
RPRX
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks StockStory - Fri Mar 21, 4:12AM CDT

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

RPRX : 31.65 (+0.29%)
COLL : 29.56 (-1.34%)
SUPN : 32.42 (+0.28%)
OGN : 14.56 (-1.02%)
ZTS : 165.02 (+1.35%)
DLTR
3 Value Stocks in Hot Water StockStory - Thu Mar 20, 8:02AM CDT

3 Value Stocks in Hot Water

RPRX : 31.65 (+0.29%)
DLTR : 76.95 (+11.18%)
SCSC : 35.44 (-0.89%)
KRT
1 Stock Under $50 with Exciting Potential and 2 to Ignore StockStory - Tue Mar 4, 7:07AM CST

1 Stock Under $50 with Exciting Potential and 2 to Ignore

RPRX : 31.65 (+0.29%)
KRT : 27.66 (-0.93%)
GXO : 40.07 (+0.40%)
CORT
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks StockStory - Tue Mar 4, 3:06AM CST

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

CORT : 56.68 (-0.75%)
RPRX : 31.65 (+0.29%)
SUPN : 32.42 (+0.28%)
OGN : 14.56 (-1.02%)
ZTS : 165.02 (+1.35%)
Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference GlobeNewswire - Thu Feb 27, 3:15PM CST

RPRX : 31.65 (+0.29%)
Fearless girl in front of bull on Wall Street by Daniel Lloyd Blunk-Fernandez via Unsplash
2 Hot Growth Stocks Poised for Gains of Up to 370%, According to Wall Street Barchart - Wed Feb 19, 6:30AM CST

These biotech companies’ strategic advancements are setting them up for long-term success.

RPRX : 31.65 (+0.29%)
JNJ : 163.13 (+0.87%)
VRTX : 502.55 (+0.45%)
SNDX : 13.56 (+3.27%)
ABBV : 202.72 (+0.71%)
GERN : 1.6500 (-2.94%)
RHHBY : 42.3500 (-0.66%)
PFE : 25.01 (-0.79%)
NTLA : 8.40 (+1.08%)
BMY : 58.90 (-0.52%)
BIIB : 140.33 (-1.47%)
Royalty Pharma Announces R&D Funding Collaboration With Biogen GlobeNewswire - Wed Feb 12, 5:30AM CST

RPRX : 31.65 (+0.29%)
Bull on Wall Street by Alexander Naumann via Pixabay
2 ‘Strong Buy’ Growth Stocks Poised for 141% to 193% Gains, According to Wall Street Barchart - Tue Feb 11, 10:29AM CST

The recent advancements in their pipelines imply high growth potential in the coming years.

ZVRA : 7.96 (+1.40%)
RPRX : 31.65 (+0.29%)
SNDX : 13.56 (+3.27%)
INCY : 60.68 (-0.95%)

Barchart Exclusives

Should You Buy the Dip in Rigetti Computing Stock in March 2025? Barchart - 1 hour ago
Rigetti Computing and other quantum computing stocks have been hit hard. So, is now the time to buy the dip? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies
Wed, Apr 02, 2025 5:00 PM UTC
Reserve Your Spot